Rare diseases
Investigational molecules
Locations
GB-0895 for Severe Uncontrolled Asthma in Adults and Adolescents
GermanyA Study of BI 764532, Atezolizumab, Carboplatin, and Etoposide in Patients With Extensive-Stage Small Cell Lung Cancer
GermanyPhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
GermanyRO7795068 for Weight Loss in Adults With Obesity or Overweight Without Type 2 Diabetes
GermanyLong-Term Study of Imeroprubart in Adults With Graves' Disease
GermanyVolrustomig in Patients with Unresectable Pleural Mesothelioma and Esophageal Squamous Cell Carcinoma
GermanyCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
GermanyFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
GermanyZenagamtide for Weight Loss in Adults with Obesity
GermanyLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
GermanyBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
GermanyHigh-Dose Colecalciferol for 28-Day Mortality in Critically Ill Adults with Severe Vitamin D Deficiency
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
